Items Tagged with 'Comments'

ARTICLES

Firms Applaud Guidance; Express Concerns About Part 11

Pharmaceutical firms have generally lauded the FDA’s efforts to advance electronic dissemination of data, according to recent industry comments posted to the agency’s “Draft Guidance for Industry on Using Electronic Means to Distribute Certain Product Information.”

Read More